6533b7d3fe1ef96bd12613bf

RESEARCH PRODUCT

CETP levels rather than polymorphisms as markers of coronary risk: Healthy athlete with high HDL-C and coronary disease—effectiveness of probucol

Maurizio AvernaCesare R. SirtoriLaura CalabresiDamiano BaldassarreAngelo B. CefalùGuido Franceschini

subject

medicine.medical_specialtybusiness.industryProbucolCoronary diseasecoronary diseasepolymorphismcoronary riskCoronary riskInternal medicineCETPCardiologyMedicineHDL-CCardiology and Cardiovascular Medicinebusinessmedicine.drughttps://doi.org/10.1016/j.atherosclerosis.2006.02.024